DLA Piper – The United States Food and Drug Administration (FDA) has released updated cybersecurity guidance titled Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions – Guidance for Industry and Food and Drug Administration Staff (Guidance), reflecting the agency’s response to the growing integration of wireless and network connected capabilities in medical devices, which has made cybersecurity controls central to device safety and effectiveness.
Cybersecurity, Privacy, & AI
Trending Now
Plankey Withdraws Nomination to Lead CISA • What Federal Leaders Need to Know About Iran’s Cyber Campaign • Navy Deploys SABER Cybersecurity System Fleetwide • The Supreme Court Is About to Decide How Far Geofence Warrants Can Go • FedRAMP Solicits Public Comment on Overhaul to Incident Communications Procedures
FDA Issues Revised Cybersecurity Premarket Submission Guidance to Align With Quality Management System Regulation
bangoland | Shutterstock
Stay compliant and protected with daily updates on cybersecurity, data privacy, and federal oversight with our Cyber & Privacy newsletter, delivering up-to-the-minute intelligence Monday–Saturday — Subscribe here.
